HIGHLIGHTS
- who: Hooi Hooi Ng from the School of BioSciences, The University of Melbourne, Melbourne, VIC, Australia, Heart Failure, Baker Heart have published the Article: Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes, in the Journal: (JOURNAL)
- what: The authors propose a small peptide hormone, relaxin, which shows a promising role in protecting the cardiovascular system (Leo et_al, 2016a; Sarwar et_al, 2017).
SUMMARY
Hyperglycemia leads to the imbalance of vasoprotective molecules such as nitric oxide (NO), prostacyclin (PGI2 ), and endothelium-derived hyperpolarization (EDH) pathways, and causes overproduction of ROS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.